Sinopharm Group Co Ltd (X2S.BE)
| Previous close | 2.5600 |
| Open | 2.5170 |
| Bid | 2.4810 x 0 |
| Ask | 2.5540 x 0 |
| Day's range | 2.5170 - 2.5170 |
| 52-week range | 2.0330 - 2.8750 |
| Volume | |
| Avg. volume | 54 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Top Dividend Stocks In Hong Kong For June 2024
As global markets navigate through mixed economic signals, Hong Kong's market shows resilience, marked by a modest uptick in the Hang Seng Index and robust retail sales growth. In such an environment, dividend stocks in Hong Kong could offer investors a blend of stability and potential income amid prevailing uncertainties.
GuruFocus.comSinopharm Group Co Ltd's Dividend Analysis
Sinopharm Group Co Ltd (SHTDF) recently announced a dividend of $0.96 per share, payable on 2024-08-13, with the ex-dividend date set for 2024-06-17. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Sinopharm Group Co Ltd's dividend performance and assess its sustainability.
- Simply Wall St.
Exploring Top Dividend Stocks In Hong Kong June 2024
As of June 2024, the Hong Kong market faces challenges, notably marked by a 2.84% drop in the Hang Seng Index amidst broader global economic uncertainties and specific regional growth headwinds. This backdrop makes it particularly pertinent for investors to consider the stability offered by dividend-paying stocks, which can provide potential income and a degree of protection in volatile markets. In this context, understanding what constitutes a resilient dividend stock becomes crucial;...
